e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury
Maitre B., Boussat S., Jean D., Gouge M., Brochard L., Housset B., Adnot S., Delclaux C.
Source:
Eur Respir J 2001; 18: 100-106
Journal Issue:
July
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maitre B., Boussat S., Jean D., Gouge M., Brochard L., Housset B., Adnot S., Delclaux C.. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 2001; 18: 100-106
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance
Source: Eur Respir J 2010; 35: 1312-1321
Year: 2010
Resolution of acute lung injury and inflammation: a translational mouse model
Source: Eur Respir J 2012; 39: 1162-1170
Year: 2012
Alveolar epithelial fluid transport in acute lung injury: new insights
Source: Eur Respir J 2002; 20: 1299-1313
Year: 2002
Mechanisms of acute lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury
Source: Eur Respir J 2009; 33: 1403-1414
Year: 2009
The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006
Increased vascular endothelial growth factor in acute eosinophilic pneumonia
Source: Eur Respir J 2003; 21: 774-778
Year: 2003
Eosinophilic pneumonia (acute, chronic)
Source: Respipedia Article
Year: 2017
Mechanical ventilation interacts with experimental low dose endotoxemia to induce apoptotic lung responses in mice
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs
Source: Eur Respir J 2007; 29: 1105-1114
Year: 2007
Regulation of PMN apoptosis in the airways during community acquired pneumonia in COPD patients and controls
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006
Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation
Source: Eur Respir J 2013; 41: 396-401
Year: 2013
E-selectin as a prognostic factor of patients who hospitalized for respiratory inflammation diseases; a single institutional study
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Source: Eur Respir J 2013; 41: 1107-1115
Year: 2013
Ventilator-induced lung injury
Source: Eur Respir J 2003; 22: 2S-9S
Year: 2003
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept